Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of Clinical Characteristics and Management of Primary Sclerosing Cholangitis and IgG4-related Sclerosing Cholangitis in China.

NCT05463445 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05463445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05463445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of Clinical Characteristics and Management of Primary Sclerosing Cholangitis and IgG4-related Sclerosing Cholangitis in China.
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 31, 2023
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

igg4-related sclerosing cholangitis, primary sclerosing cholangitis